Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

aap Implantate AG issues FY 2014 Q3 outlook and reaffirms FY 2014 outlook


Wednesday, 13 Aug 2014 08:00pm EDT 

aap Implantate AG:Expects sales for Q3 to be between 7.0 million and 8.0 million euros.Expects EBITDA for Q3 to be between 0.0 million and 0.4 million euros.Reaffirms sales and EBITDA outlook for FY 2014 with sales of 35 million euros and EBITDA of between 5 million and 6 million euros.